Article
Neoadjuvant immunotherapy plus chemotherapy achieved pathologic complete response in stage IIIB lung adenocarcinoma harbored EGFR G779F: a case report.
Annals of palliative medicine - 1 Nov 2020
Wang Yadong, Yang Xiaoying, Tian Xu, Jia Ziqi, Bing Zhongxing, Cao Lei, Gao Chao, Cao Zhili, Li Shanqing, Liang Naixin
Abstract excerpt
The majority of patients with lung cancer are in the late stage (stages IIIB or IV) when diagnosed. However, clinical features, treatment and prognosis of some patients in stage IIIB are somewhat different from those in stage IV. Several clinical trials of neoadjuvant immunotherapy are changing the treatment strategy for patients with stage IB-IIIA non-small cell lung cancer (NSCLC). It remains unclear whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.